Lubrizol LifeSciences adds new compounding capabilities
This will help Lubrizol to strengthen its position in medical device applications sector
)
premium
Medical device
The Lubrizol Corporation’s LifeSciences (LLS) business has added compounding capabilities for its Pellethane and Isoplast products for medical device customers. This new offering enables Lubrizol Corporation, a Berkshire Hathaway company, to provide colour matching, radiopacity and custom compound development services and complements lifesciences’ existing polymer portfolio, formulation and manufacturing capabilities to enable success for medical device customers.